MedPath

Zidmax

Brand Name: Zidmax

Generic Name: Ceftazidime (As Pentahydrate)

Active
Registration Number

DRP-11577

Dosage Form

Powder For Injection (I.M./I.V.)

Issuance Date

March 31, 2022

Expiry Date

March 31, 2027

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength1g
Packaging20 mL USP Type III clear glass vial sealed with grey butyl bromo stopper and pink colored flip-off + LDPE ampoule containing Sterile Water for Injection as diluent x 10 mL (Box of 1's)

Classification

C
Classification
Prescription Drug (RX)
P
Pharmacologic
Third Generation Cephalosporin
A
Application
Initial
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

Ceftazidime (As Pentahydrate)Active
Monograph: ceftazidime (as pentahydrate)

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform